Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Dividends payables (2016 - 2020)

Historic Dividends payables for Medifast (MED) over the last 6 years, with Q4 2020 value amounting to $13.8 million.

  • Medifast's Dividends payables rose 81.64% to $13.8 million in Q4 2020 from the same period last year, while for Dec 2020 it was $13.8 million, marking a year-over-year increase of 81.64%. This contributed to the annual value of $13.8 million for FY2020, which is 81.64% up from last year.
  • Medifast's Dividends payables amounted to $13.8 million in Q4 2020, which was up 81.64% from $13.7 million recorded in Q4 2019.
  • In the past 5 years, Medifast's Dividends payables ranged from a high of $13.8 million in Q4 2020 and a low of $4.0 million during Q4 2016
  • Moreover, its 5-year median value for Dividends payables was $9.1 million (2018), whereas its average is $9.4 million.
  • Its Dividends payables has fluctuated over the past 5 years, first skyrocketed by 5115.13% in 2017, then skyrocketed by 81.64% in 2020.
  • Quarter analysis of 5 years shows Medifast's Dividends payables stood at $4.0 million in 2016, then soared by 51.15% to $6.1 million in 2017, then surged by 49.66% to $9.1 million in 2018, then skyrocketed by 50.15% to $13.7 million in 2019, then grew by 0.82% to $13.8 million in 2020.
  • Its Dividends payables stands at $13.8 million for Q4 2020, versus $13.7 million for Q4 2019 and $9.1 million for Q4 2018.